Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Collins

Showing results (1551-1560 of 1,952) with videos related to

Pageof 196
Sort By:
Breast Cancer Research : BCR|March 7, 2023
Prolactin levels and breast cancer risk by tumor expression of prolactin-related markersCassandra A Hathaway, Megan S Rice, Laura C Collins, et al.
Haematologica|August 3, 2023
Hypomethylating agent decitabine sensitizes diffuse large B-cell lymphoma to venetoclaxFen Zhu, Jennifer L Crombie, Wei Ni, et al.
Nucleic Acids Research|February 14, 2019
Structural variation and fusion detection using targeted sequencing data from circulating cell free DNAAlexander R Gawroński, Yen-Yi Lin, Brian McConeghy, et al.
NPJ Breast Cancer|October 6, 2017
Breast cancer risk factors in relation to estrogen receptor, progesterone receptor, insulin-like growth factor-1 receptor, and Ki67 expression in normal breast tissueHannah Oh, A Heather Eliassen, Andrew H Beck, et al.
International Journal of Radiation Oncology, Biology, Physics|June 8, 2006
Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapyLoren K Mell, Joel D Kochanski, John C Roeske, et al.
Cancer Causes & Control : CCC|January 3, 2020
Sexual orientation and benign breast disease in a cohort of U.S. womenBrittany M Charlton, Leslie V Farland, Ulrike Boehmer, et al.
Molecular Oncology|February 19, 2019
The long noncoding RNA HORAS5 mediates castration-resistant prostate cancer survival by activating the androgen receptor transcriptional programAbhijit Parolia, Erik Venalainen, Hui Xue, et al.
Oncogene|April 3, 1997
ESX: a structurally unique Ets overexpressed early during human breast tumorigenesisC H Chang, G K Scott, W L Kuo, et al.
Cancer Causes & Control : CCC|November 8, 2014
Intakes of fat and micronutrients between ages 13 and 18 years and the incidence of proliferative benign breast diseaseXuefen Su, Caroline E Boeke, Laura C Collins, et al.
Vascular|November 17, 2022
Race differences in iliofemoral vein stenting for chronic venous insufficiencyLogan D Cho, Halbert Bai, Lucas C Collins, et al.
Pageof 196

Showing results (1551-1560 of 1,952) with videos related to

Sort By:
Pageof 196
Breast Cancer Research : BCR|March 7, 2023
Prolactin levels and breast cancer risk by tumor expression of prolactin-related markersCassandra A Hathaway, Megan S Rice, Laura C Collins, et al.
Haematologica|August 3, 2023
Hypomethylating agent decitabine sensitizes diffuse large B-cell lymphoma to venetoclaxFen Zhu, Jennifer L Crombie, Wei Ni, et al.
Nucleic Acids Research|February 14, 2019
Structural variation and fusion detection using targeted sequencing data from circulating cell free DNAAlexander R Gawroński, Yen-Yi Lin, Brian McConeghy, et al.
NPJ Breast Cancer|October 6, 2017
Breast cancer risk factors in relation to estrogen receptor, progesterone receptor, insulin-like growth factor-1 receptor, and Ki67 expression in normal breast tissueHannah Oh, A Heather Eliassen, Andrew H Beck, et al.
International Journal of Radiation Oncology, Biology, Physics|June 8, 2006
Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapyLoren K Mell, Joel D Kochanski, John C Roeske, et al.
Cancer Causes & Control : CCC|January 3, 2020
Sexual orientation and benign breast disease in a cohort of U.S. womenBrittany M Charlton, Leslie V Farland, Ulrike Boehmer, et al.
Molecular Oncology|February 19, 2019
The long noncoding RNA HORAS5 mediates castration-resistant prostate cancer survival by activating the androgen receptor transcriptional programAbhijit Parolia, Erik Venalainen, Hui Xue, et al.
Oncogene|April 3, 1997
ESX: a structurally unique Ets overexpressed early during human breast tumorigenesisC H Chang, G K Scott, W L Kuo, et al.
Cancer Causes & Control : CCC|November 8, 2014
Intakes of fat and micronutrients between ages 13 and 18 years and the incidence of proliferative benign breast diseaseXuefen Su, Caroline E Boeke, Laura C Collins, et al.
Vascular|November 17, 2022
Race differences in iliofemoral vein stenting for chronic venous insufficiencyLogan D Cho, Halbert Bai, Lucas C Collins, et al.
Pageof 196